CANCER IMMUNOLOGY IMMUNOTHERAPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2025-09-20 Cassie2696 来自上海

偏重的研究方向：肿瘤免疫
经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲

98 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2021-10-06 Ykkkk

请问文章接收多久后能收到版权协议和proof？

248 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2022-02-06 148202a4m20(暂无昵称)

请问已经under review11个月了，发邮件没有回复，这种情况怎么办？

181 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2025-01-09 扣1992 来自黑龙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！

100 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2024-12-01 stayreal1992 来自山东省

偏重的研究方向：肿瘤;肿瘤免疫
经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了

104 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2024-12-12 空漠菌来自北京

偏重的研究方向：肿瘤免疫
经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。
另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀

107 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2022-08-24 ms3000000087643737

请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。

230 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2022-12-24 actin 5 来自湖北省

审稿速度:4.0
偏重的研究方向：免疫;肿瘤免疫
经验分享：变三区了，性价比不高

253 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2022-09-02 ms3000001278720978

偏重的研究方向：肿瘤
经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办

231 12 举报

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2282030, encodeId=7c162282030f6, content=偏重的研究方向：肿瘤免疫 经验分享：文章接收后多久收到proof呀？我已经接收10天了都没收到邮件😲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/10/9fdf15d0a290dd06fdba819b71088a42.jpg, createdBy=b6ef2564439, createdName=Cassie2696, createdTime=Sat Sep 20 19:48:07 CST 2025, time=2025-09-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：请问各位朋友一般with editor 多久才会送审已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫 经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。 另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=)]

2022-11-07 ms1000001339998745

审稿速度:6.0 | 投稿命中率:25.0
经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿

233 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务